Top

Published in:

01-08-2020 | Anakinra

SARS-COV-2 and eye immunity: the lesson was learned but we are not done yet. Brainstorming on possible pathophysiology inspired by ocular models

Authors: Piergiorgio Neri, Massimo Lamperti, Francesco Pichi

Published in: International Ophthalmology | Issue 8/2020

Excerpt

Since its outbreak in early 2020, the novel coronavirus Severe Acute Respiratory Syndrome (SARS)-COV-2, formerly known as Covid-19, has affected more than 5 million people worldwide with a mortality rate of about 6.6%, making it roughly 6 times more lethal than influenza virus [1]. …

WHO (2020) Coronavirus disease 2019 (COVID-19) situation report—126. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200525-covid-19-sitrep-126.pdf?sfvrsn=887dbd66_2

Vetrugno L, Bove T, Orso D et al (2020) Our Italian experience using lung ultrasound for identification, grading and serial follow-up of severity of lung involvement for management of patients with COVID-19. Echocardiography 37(4):625–627. https://doi.org/10.1111/echo.14664 CrossRefPubMed

Diotallevi F, Campanati A, Bianchelli T et al (2020) Skin involvement in SARS-CoV-2 infection: case series. J Med Virol. https://doi.org/10.1002/jmv.26012 CrossRefPubMedPubMedCentral

Asadi-Pooya AA, Simani L (2020) Central nervous system manifestations of COVID-19: a systematic review. J Neurol Sci 413:116832. https://doi.org/10.1016/j.jns.2020.116832 CrossRefPubMedPubMedCentral

Mao R, Qiu Y, He JS et al (2020) Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. https://doi.org/10.1016/S2468-1253(20)30126-6 CrossRefPubMedPubMedCentral

Marinho PM, Marcos AAA, Romano AC et al (2020) Retinal findings in patients with COVID-19. Lancet 395(10237):1610. https://doi.org/10.1016/S0140-6736(20)31014-X CrossRefPubMedPubMedCentral

Menter T, Haslbauer JD, Nienhold R et al (2020) Post-mortem examination of COVID19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings of lungs and other organs suggesting vascular dysfunction. Histopathology. https://doi.org/10.1111/his.14134 CrossRefPubMedPubMedCentral

Liu K, Chen Y, Lin R et al (2020) Clinical features of COVID-19 in elderly patients: a comparison with young and middle-aged patients. J Infect 80(6):e14–e18. https://doi.org/10.1016/j.jinf.2020.03.005 CrossRefPubMedPubMedCentral

Mehta P, McAuley DF, Brown M et al (2020) COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 395(10229):1033CrossRefPubMedPubMedCentral

10.

Schulert GS, Cron RQ (2020) The genetics of macrophage activation syndrome. Genes Immun. https://doi.org/10.1038/s41435-020-0098-4 CrossRefPubMed

11.

Shang L, Zhao J, Hu Y et al (2020) On the use of corticosteroids for 2019-nCoV pneumonia. Lancet 395(10225):683–684CrossRefPubMedPubMedCentral

12.

Stahl JP, Mailles A (2019) Herpes simplex virus encephalitis update. Curr Opin Infect Dis 32(3):239–243CrossRefPubMed

13.

Xu J, Tan DY, Fu YY et al (2015) Do corticosteroids have a role in treating Ebola virus disease? Sci China Life Sci 58(1):111–113CrossRefPubMed

14.

Pilotto A, Odolini S, Stefano Masciocchi S et al (2020) Steroid-responsive encephalitis in Covid-19 disease. Ann Neurol. https://doi.org/10.1002/ana.25783 CrossRefPubMedPubMedCentral

15.

Ledford H (2020) Coronavirus breakthrough: dexamethasone is first drug shown to save lives. Nature. https://doi.org/10.1038/d41586-020-01824-5 CrossRefPubMed

16.

Neri P, Pichi F (2020) COVID-19 and the eye immunity: lesson learned from the past and possible new therapeutic insights. Int Ophthalmol 40(5):1057–1060. https://doi.org/10.1007/s10792-020-01389-2 CrossRefPubMedPubMedCentral

17.

Scott LJ (2017) Tocilizumab: a review in rheumatoid arthritis [published correction appears in Drugs. 2017 Dec 19]. Drugs 77(17):1865–1879. https://doi.org/10.1007/s40265-017-0829-7 CrossRefPubMedPubMedCentral

18.

Wang Z, Wu Z, Liu Y et al (2017) New development in CAR-T cell therapy. J Hematol Oncol 10(1):53. https://doi.org/10.1186/s13045-017-0423-1 CrossRefPubMedPubMedCentral

19.

Zhang C, Wu Z, Li JW et al (2020) The cytokine release syndrome (CRS) of severe COVID-19 and Interleukin-6 receptor (IL-6R) antagonist Tocilizumab may be the key to reduce the mortality. Int J Antimicrob Agents 29:105954. https://doi.org/10.1016/j.ijantimicag.2020.105954 CrossRef

20.

Hooper LC, Chin MS, Detrick B et al (2005) Retinal degeneration in experimental coronavirus retinopathy (ECOR) is associated with increased TNF-alpha, soluble TNFR2 and altered TNF-alpha signaling. J Neuroimmunol 166(1–2):65–74. https://doi.org/10.1016/j.jneuroim.2005.05.018 CrossRefPubMedPubMedCentral

21.

Tay MZ, Poh CM, Rénia L et al (2020) The trinity of COVID-19: immunity, inflammation and intervention. Nat Rev Immunol. https://doi.org/10.1038/s41577-020-0311-8 CrossRefPubMedPubMedCentral

22.

Oxley TJ, Mocco J, Majidi S et al (2020) Large-vessel stroke as a presenting feature of Covid-19 in the young. N Engl J Med 382(20):e60. https://doi.org/10.1056/NEJMc2009787 CrossRefPubMed

23.

Toniati P, Piva S, Cattalini M et al (2020) Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: a single center study of 100 patients in Brescia Italy. Autoimmun Rev. https://doi.org/10.1016/j.autrev.2020.102568 CrossRefPubMedPubMedCentral

24.

Xu X, Han M, Li T et al (2020) Effective treatment of severe COVID-19 patients with tocilizumab. Proc Natl Acad Sci USA 117(20):10970–10975. https://doi.org/10.1073/pnas.2005615117 CrossRefPubMedPubMedCentral

25.

Radbel J, Narayanan N, Bhatt PJ (2020) Use of Tocilizumab for COVID-19-induced cytokine release syndrome: a cautionary case report. Chest S0012–3692(20):30764–9. https://doi.org/10.1016/j.chest.2020.04.024 CrossRef

26.

Teoh SC, Sharma S, Hogan A et al (2007) Tailoring biological treatment: anakinra treatment of posterior uveitis associated with the CINCA syndrome. Br J Ophthalmol 91(2):263–264. https://doi.org/10.1136/bjo.2006.0101477 CrossRefPubMedPubMedCentral

27.

Dimopoulos G, de Mast Q, Markou N et al (2020) Favorable anakinra responses in severe covid-19 patients with secondary hemophagocytic lymphohistiocytosis. Cell Host Microbe. https://doi.org/10.1016/j.chom.2020.05.007 CrossRefPubMedPubMedCentral

28.

A trial of validation and restoration of immune dysfunction in severe infections and sepsis (PROVIDE). https://clinicaltrials.gov/ct2/show/NCT03332225

29.

Liang L, Tan X, Zhou Q et al (2013) IL-1β triggered by peptidoglycan and lipopolysaccharide through TLR2/4 and ROS-NLRP3 inflammasome-dependent pathways is involved in ocular Behçet's disease. Invest Ophthalmol Vis Sci 54(1):402–414. https://doi.org/10.1167/iovs.12-11047 CrossRefPubMed

30.

Zhao C, Zhao W (2020) NLRP3 inflammasome-a key player in antiviral responses. Front Immunol 11:211. https://doi.org/10.3389/fimmu.2020.00211 CrossRefPubMedPubMedCentral

31.

Nieto-Torres JL, Verdia-Baguena C, Jimenez-Guardeno JM et al (2015) Severe acute respiratory syndrome coronavirus E protein transports calcium ions and activates the NLRP3 inflammasome. Virology 485:330–339. https://doi.org/10.1016/j.virol.2015.08.010 CrossRefPubMed

32.

Niu JL, Wu SX, Chen MK et al (2019) Hyperactivation of the NLRP3 inflammasome protects mice against influenza A virus infection via IL-1 beta mediated neutrophil recruitment. Cytokine 120:115–124. https://doi.org/10.1016/j.cyto.2019.04.019 CrossRefPubMed

33.

Kernan KF, Ghaloul-Gonzalez L, Shakoory B et al (2019) Adults with septic shock and extreme hyperferritinemia exhibit pathogenic immune variation. Genes Immun 20(6):520–526. https://doi.org/10.1038/s41435-018-0030-3 CrossRefPubMed

34.

Monteagudo LA, Boothby A, Gertner E (2020) Continuous intravenous anakinra infusion to calm the cytokine storm in macrophage activation syndrome. ACR Open Rheumatol 2(5):276–282. https://doi.org/10.1002/acr2.11135 CrossRefPubMedPubMedCentral

35.

Norelli M, Camisa B, Barbiera G et al (2018) Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells. Nat Med 24(6):739–748. https://doi.org/10.1038/s41591-018-0036-4 CrossRefPubMed

36.

Verdoni L, Mazza A, Gervasoni A et al (2020) An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet. https://doi.org/10.1016/S0140-6736(20)31103-X CrossRefPubMedPubMedCentral

37.

Anzai F, Watanabe S, Kimura H et al (2020) Crucial role of NLRP3 inflammasome in a murine model of Kawasaki disease. J Mol Cell Cardiol 138:185–196. https://doi.org/10.1016/j.yjmcc.2019.11.158 CrossRefPubMed

Title: SARS-COV-2 and eye immunity: the lesson was learned but we are not done yet. Brainstorming on possible pathophysiology inspired by ocular models
Authors: Piergiorgio Neri
Massimo Lamperti
Francesco Pichi
Publication date: 01-08-2020
Publisher: Springer Netherlands
Keywords: Anakinra
Tocilizumab
SARS-CoV-2
Published in: International Ophthalmology / Issue 8/2020
Print ISSN: 0165-5701
Electronic ISSN: 1573-2630
DOI: https://doi.org/10.1007/s10792-020-01495-1

At a glance: The STEP trials

Springer Medicine

SARS-COV-2 and eye immunity: the lesson was learned but we are not done yet. Brainstorming on possible pathophysiology inspired by ocular models

Excerpt

At a glance: The STEP trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 8/2020

Anterior chamber angle width, central vault and intraocular pressure changes after 12 months of Visian collamer lens implantation

Combined aspirin and clopidogrel therapy in phacoemulsification cataract surgery: a risk factor for ocular hemorrhage?

The effect of topical tropicamide and phenylephrine on macular and peripapillary microvasculature: an optical coherence tomography angiography study

Is there a relationship between hypoparathyroidism and retinal microcirculation?

Predictive factors for the IOP reduction in phacocanaloplasty with suprachoroidal drainage

Intraocular lens power calculation in a posterior chamber phakic intraocular lens implanted eye